Adagio Medical is a developmental stage medical device company located in Laguna Hills, California and focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
Company profile
Ticker
ADGM
Exchange
CEO
Mr. Olav B. Bergheim
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • GE HealthCare • Uber • The Kraft Heinz Company • Lineage • Boston Scientific • Organon & Co. • Life Time • Teleflex • Acadia Healthcare ...
Former names
Aja Holdco, Inc.
SEC CIK
ADGM stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
8 Oct 24
EFFECT
Notice of effectiveness
20 Sep 24
EFFECT
Notice of effectiveness
20 Sep 24
424B3
Prospectus supplement
19 Sep 24
424B3
Prospectus supplement
19 Sep 24
S-1
IPO registration
13 Sep 24
S-1
IPO registration
13 Sep 24
10-Q
2024 Q2
Quarterly report
26 Aug 24
8-K
Adagio Medical Provides Business Updates
19 Aug 24
8-K/A
Completion of Acquisition or Disposition of Assets
14 Aug 24
Latest ownership filings
Financial summary
Quarter (USD) | Jun 24 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Sep 24 | Sciences Holdings IV ARYA | Common Stock | Other | Dispose J | No | No | 0 | 3,501,600 | 0.00 | 0 |